IRIS International, Inc. develops, manufactures and markets in vitro diagnostic (IVD) products, including IVD imaging systems based on neural network-based automated particle recognition (APR) software to enable high-speed digital processing to classify and display images and describe the morphology of microscopic particles, urine chemistry analyzer and related chemistry test strips and accessories, molecular diagnostics assays based on its nucleic acid detection immuno-assay (NADiA) technology, as well as special purpose centrifuges and other small instruments for automating microscopic procedures and deoxyribonucleic acid (DNA) processing performed in clinical laboratories. Its commercialized products and product pipeline comprise three categories: morphology, molecular diagnostics and sample processing.